EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme

Bryan W. Day(QIMR Berghofer Medical Research Institute), Brett W. Stringer(QIMR Berghofer Medical Research Institute), Fares Al‐Ejeh(QIMR Berghofer Medical Research Institute), Michael J. Ting(QIMR Berghofer Medical Research Institute), John C. Wilson(The University of Queensland), Kathleen S. Ensbey(QIMR Berghofer Medical Research Institute), Paul R. Jamieson(QIMR Berghofer Medical Research Institute), Zara C. Bruce(QIMR Berghofer Medical Research Institute), Yi Chieh Lim(QIMR Berghofer Medical Research Institute), Carolin Offenhäuser(QIMR Berghofer Medical Research Institute), Sara Charmsaz(QIMR Berghofer Medical Research Institute), Leanne Cooper(QIMR Berghofer Medical Research Institute), Jennifer K. Ellacott(QIMR Berghofer Medical Research Institute), Angus Harding(The University of Queensland), Lucie Leveque(QIMR Berghofer Medical Research Institute), Po Inglis(QIMR Berghofer Medical Research Institute), Suzanne Allan(QIMR Berghofer Medical Research Institute), David G. Walker, Martin Lackmann(Monash University), Geoffrey W. Osborne(The University of Queensland), Kum Kum Khanna(QIMR Berghofer Medical Research Institute), Brent A. Reynolds(University of Florida), Jason D. Lickliter(QIMR Berghofer Medical Research Institute), Andy Boyd(The University of Queensland)
Cancer Cell
February 1, 2013
10.1016/j.ccr.2013.01.007
Cited by 215Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis